Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
about
Quality-of-life effects of prostate-specific antigen screening.Economic analyses of human genetics services: a systematic review.Genetic testing in the European Union: does economic evaluation matter?Is individualized medicine more cost-effective? A systematic review.Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review.A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer.Cost effectiveness of risk-prediction tools in selecting patients for immediate post-prostatectomy treatment.
P2860
Q34294102-ECAD0F2C-C0DF-4BDF-B6F4-F44C998E96F4Q36296074-768CD381-5D5E-4763-82E9-A85D605B2D62Q37877618-60CCE0E8-E987-4182-A597-90A3733C8A5DQ38191496-5DBC3539-A5FF-4DB9-9982-2207D3E52DDAQ38267878-A8E54684-7DA8-4B69-8274-E199D6606C77Q45307605-37E70603-71B3-4F82-9806-98CC6EC8B766Q51731303-530AE814-AED9-4F8B-AC90-642843B8324C
P2860
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
@en
type
label
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
@en
prefLabel
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
@en
P2093
P2860
P356
P1476
Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
@en
P2093
A B Morgan
N W Calvert
R L Akehurst
P2860
P2888
P356
10.1038/SJ.BJC.6600630
P407
P577
2003-01-01T00:00:00Z
P5875
P6179
1040893008